CIK 0000310158 · Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221918501
- Phone
- 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-02 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Grant or award · Stock Option (Right to Buy) | +45,643 | 45,643 | ||
| 2023-05-02 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Grant or award · Stock Option (Right to Buy) | +44,260 | 44,260 | ||
| 2023-05-02 | Davis Robert M Chairman, CEO & President | Grant or award · Stock Option (Right to Buy) | +186,722 | 186,722 | ||
| 2023-05-02 | Oosthuizen Johannes Jacobus President, U.S. Market | Grant or award · Stock Option (Right to Buy) | +20,747 | 20,747 | ||
| 2023-05-02 | Li Dean Y Executive VP & President, MRL | Grant or award · Stock Option (Right to Buy) | +77,455 | 77,455 | ||
| 2023-05-02 | Romanelli Joseph President, Human Health Int?l | Grant or award · Stock Option (Right to Buy) | +23,513 | 23,513 | ||
| 2023-05-02 | Romanelli Joseph President, Human Health Int?l | Grant or award · Restricted Stock Unit | +6,786 | 6,786 | ||
| 2023-05-02 | Downing Cristal N Chief Comm. & Public Afrs Ofcr | Grant or award · Stock Option (Right to Buy) | +17,981 | 17,981 | ||
| 2023-05-02 | Guindo Chirfi Chief Marketing Officer | Grant or award · Stock Option (Right to Buy) | +34,578 | 34,578 | ||
| 2023-05-02 | MIZELL STEVEN EVP, Chief HR Officer | Grant or award · Stock Option (Right to Buy) | +29,046 | 29,046 | ||
| 2023-05-02 | Zachary Jennifer EVP, General Counsel | Grant or award · Stock Option (Right to Buy) | +41,494 | 41,494 | ||
| 2023-05-02 | Williams David Michael EVP,Chief Info&Digital Officer | Option exercise | +6,035 | $56.04 | $338K | 18,567.96 |
| 2023-05-02 | Williams David Michael EVP,Chief Info&Digital Officer | Sale | −7,509 | $116.82 | $877K | 11,058.96 |
| 2023-05-02 | Williams David Michael EVP,Chief Info&Digital Officer | Option exercise · Stock Option (Right to Buy) | −6,035 | 0 | ||
| 2023-05-01 | Williams David Michael EVP,Chief Info&Digital Officer | Option exercise | +577 | $115.47 | $67K | 12,730.96 |
| 2023-05-01 | Williams David Michael EVP,Chief Info&Digital Officer | Shares withheld for taxes | −198 | $115.47 | $23K | 12,532.96 |
| 2023-05-01 | Williams David Michael EVP,Chief Info&Digital Officer | Option exercise · Restricted Stock Unit | −577 | 0 | ||
| 2023-05-01 | Karachun Rita A Sr. VP Fince-Global Controller | Option exercise | +930 | $115.47 | $107K | 44,878.97 |
| 2023-05-01 | Karachun Rita A Sr. VP Fince-Global Controller | Shares withheld for taxes | −319 | $115.47 | $37K | 44,559.97 |
| 2023-05-01 | Karachun Rita A Sr. VP Fince-Global Controller | Option exercise · Restricted Stock Unit | −930 | 0 |
Page 24 of 29 · 572 trades